Peritoneal tuberculosis after imatinib therapy.
| Data(s) |
01/02/2009
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_C2958BC219EE isbn:1538-3679 pmid:19204223 doi:10.1001/archinternmed.2008.581 http://my.unil.ch/serval/document/BIB_C2958BC219EE.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C2958BC219EE9 isiid:000263202600015 |
| Idioma(s) |
en |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
Archives of Internal Medicine, vol. 169, no. 3, pp. 312-313 |
| Palavras-Chave | #Adult; Antineoplastic Agents; Antitubercular Agents; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphopenia; Male; Opportunistic Infections; Peritonitis; Peritonitis, Tuberculous; Piperazines; Pyrimidines |
| Tipo |
info:eu-repo/semantics/article article |
